使用与药物动力学模型集成的深度神经网络预测小鼠的血度-时间概况
Yuki Doi1, Harutoshi Kato2, Fumiyoshi Yamashita3
1DMPK Research Laboratories, Mitsubishi Tanabe Pharma Corporation, Kanagawa 251-8555, Japan; Department of Quantitative Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
International journal of pharmaceutics
|April 18, 2025
概括
这项研究引入了一种新的定量结构-活性关系 (QSAR) 方法,用于预测药理动力学 (PK) 概况. 新的深度学习方法通过直接使用体内PK数据来提高准确性,克服了传统曲线拟合方法的局限性.
科学领域:
- 药理动力学 药理动力学
- 计算化学的计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 定量结构-活性关系 (QSAR) 方法对于预测体内药物行为至关重要.
- 传统的药理动力学 (PK) QSAR模型受到曲线拟合错误的限制.
- 准确预测PK参数,如清除和分布量,对于药物开发至关重要.
研究的目的:
- 开发一种新的QSAR方法,将深度神经网络与两部分模型集成在一起,以改进PK预测.
- 通过直接利用体内PK数据来解决现有的QSAR技术的局限性.
- 为了提高候选药物的血度-时间概况的预测准确度.
主要方法:
- 通过将深度神经网络与两部分模型集成,开发了一种新的QSAR模型.
- 该模型使用化学结构和体外/内ADME特征作为输入.
- 培训是在30个项目中的1,162种化合物的体内小鼠PK数据上进行的,通过5倍交叉验证进行评估.
主要成果:
- 与传统方法相比,该新方法证明了与传统方法相比,血度-时间概况的预测准确度有所提高.
- 静脉注射的R2值中位数从0.530到0.673不等,口服的R2值从0.119到0.432.
- 综合梯度分析揭示了与已确定的药理动力学原则相一致的特征影响.
结论:
- 拟议的QSAR方法在预测体内PK配置文件方面提供了增强的性能.
- 这种方法为分子结构,ADME特性和PK结果之间的关系提供了宝贵的见解.
- 这些发现支持深度学习集成的实用性,用于药物发现中的强大的药理动力学建模.
更多相关视频
相关概念视频
Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Model Approaches for Pharmacokinetic Data: Compartment Models
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...


